5 Stocks Under Wall Street’s Radar: Stemline Therapeutics, Inc. (NASDAQ:STML), MannKind Corp. (NASDAQ:MNKD), Bristol-Myers Squibb Company (NYSE:BMY), OXiGENE, Inc.

Stemline Therapeutics, Inc. (NASDAQ:STML) announced that Ivan Bergstein, M.D., Stemline’s CEO, will present at the Cowen and Company 36th Annual Health Care Conference on Wednesday, March 9, 2016 at 8:40 AM ET.

Stemline Therapeutics, Inc. (NASDAQ:STML) belongs to Healthcare sector. Its weekly performance is 22.94%. On last trading day company shares ended up at $5.68. Stemline Therapeutics, Inc. (NASDAQ:STML) distance from 50-day simple moving average (SMA50) is 3.72%.

MannKind Corp. (NASDAQ:MNKD) announced that it has withdrawn its offer to employ Duane M. DeSisto as its President and Chief Executive Officer as a consequence of objections raised by Insulet Corp., the former employer of DeSisto, that the employment of DeSisto by MannKind would violate Insulet’s non-competition agreement with DeSisto, which is in effect until Sept. 17, 2016.

MannKind Corp. (NASDAQ:MNKD) shares advanced 6.36% in last trading session and ended the day at $1.17. MNKD return on assets is -36.90%. MannKind Corp. (NASDAQ:MNKD) quarterly performance is -46.08%.

Bristol-Myers Squibb Company (NYSE:BMY) will present at the Cowen and Company 36th Annual Global Health Care Conference on Monday, March 7, 2016, in Boston. Fouad Namouni, senior vice president, Head of Medical, will make a formal presentation about the company at 1:20 p.m. EST.

On 04 March, Bristol-Myers Squibb Company (NYSE:BMY) shares decreased -0.45% and was closed at $64.71. BMY EPS growth in last 5 year was -12.30%. Bristol-Myers Squibb Company (NYSE:BMY) year to date (YTD) performance is -5.93%.

OXiGENE Inc (NASDAQ:OXGN) had its target price trimmed by S&P Equity Research from $0.64 to $0.58 in a report issued on Friday morning, Marketbeat reports.

OXiGENE, Inc. (NASDAQ:OXGN) ended the last trading day at $0.64. Company weekly volatility is calculated as 8.46% and price to cash ratio as 0.56. OXiGENE, Inc. (NASDAQ:OXGN) showed a weekly performance of 9.38%.

On 29 February, New Mountain Finance Corporation (NYSE:NMFC) announced its financial results for the quarter and year ended December 31, 2015 and reported fourth quarter adjusted net investment income1 of $0.35 per weighted average share. Pro forma adjusted net investment income per weighted average share for the year ended December 31, 2015 was $1.39. At December 31, 2015, net asset value (“NAV”) per share was $13.08, a decrease of $0.65 per share from September 30, 2015, a decrease of $0.75 per share from December 31, 2014, and within management’s most recent guidance of $13.00 to $13.10 per share. The Company also announced that its board of directors declared a first quarter dividend of $0.34 per share, which will be payable on March 31, 2016 to holders of record as of March 17, 2016.

New Mountain Finance Corporation (NYSE:NMFC) shares increased 0.87% in last trading session and ended the day at $12.69. NMFC Gross Margin is 57.20% and its return on assets is 3.00%. New Mountain Finance Corporation (NYSE:NMFC) quarterly performance is -7.59%.

Leave a Reply

Your email address will not be published. Required fields are marked *